Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
NCT00794144
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Rhinitis
Interventions
DRUG:
Olopatadine Hydrochloride Nasal Spray 0.6%
DRUG:
Olopatadine Hydrochloride Nasal Spray Vehicle
Sponsor
Alcon Research